Clinical Trial Update: Therapies for Down Syndrome Regression Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for therapies addressing Down Syndrome Regression Disorder. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Snippet

Sponsor: University of Colorado, Denver | Conditions: Down Syndrome, Regression | Phase 2 | Status: ACTIVE_NOT_RECRUITING